In the Matter of NMI Health, Inc., Order of Suspension of Trading, 55410 [2015-23238]

Download as PDF 55410 Federal Register / Vol. 80, No. 178 / Tuesday, September 15, 2015 / Notices review revenue and expenses annually to determine if any adjustments should be made to account for changes in expenses associated with the delivery and support of all testing programs. C. Self-Regulatory Organization’s Statement on Comments on the Proposed Rule Change Received From Members, Participants, or Others Written comments were neither solicited nor received. III. Date of Effectiveness of the Proposed Rule Change and Timing for Commission Action The foregoing rule change has become effective pursuant to Section 19(b)(3)(A) of the Act 10 and paragraph (f)(2) of Rule 19b–4 thereunder.11 At any time within 60 days of the filing of the proposed rule change, the Commission summarily may temporarily suspend such rule change if it appears to the Commission that such action is necessary or appropriate in the public interest, for the protection of investors, or otherwise in furtherance of the purposes of the Act. If the Commission takes such action, the Commission shall institute proceedings to determine whether the proposed rule should be approved or disapproved. IV. Solicitation of Comments Interested persons are invited to submit written data, views, and arguments concerning the foregoing, including whether the proposed rule change is consistent with the Act. Comments may be submitted by any of the following methods: mstockstill on DSK4VPTVN1PROD with NOTICES Electronic Comments • Use the Commission’s Internet comment form (https://www.sec.gov/ rules/sro.shtml); or • Send an email to rule-comments@ sec.gov. Please include File Number SR– FINRA–2015–031 on the subject line. Paper Comments • Send paper comments in triplicate to Brent J. Fields, Secretary, Securities and Exchange Commission, 100 F Street NE., Washington, DC 20549–1090. All submissions should refer to File Number SR–FINRA–2015–031. This file number should be included on the subject line if email is used. To help the Commission process and review your comments more efficiently, please use only one method. The Commission will post all comments on the Commission’s Internet Web site (https://www.sec.gov/ rules/sro.shtml). Copies of the submission, all subsequent 10 15 11 17 U.S.C. 78s(b)(3)(A). CFR 240.19b–4(f)(2). VerDate Sep<11>2014 19:04 Sep 14, 2015 amendments, all written statements with respect to the proposed rule change that are filed with the Commission, and all written communications relating to the proposed rule change between the Commission and any person, other than those that may be withheld from the public in accordance with the provisions of 5 U.S.C. 552, will be available for Web site viewing and printing in the Commission’s Public Reference Room, 100 F Street NE., Washington, DC 20549 on official business days between the hours of 10:00 a.m. and 3:00 p.m. Copies of such filing also will be available for inspection and copying at the principal office of FINRA. All comments received will be posted without change; the Commission does not edit personal identifying information from submissions. You should submit only information that you wish to make available publicly. All submissions should refer to File Number SR–FINRA– 2015–031, and should be submitted on or before October 6, 2015. For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.12 Robert W. Errett, Deputy Secretary. [FR Doc. 2015–23095 Filed 9–14–15; 8:45 am] BILLING CODE 8011–01–P SECURITIES AND EXCHANGE COMMISSION [File No. 500–1] In the Matter of NMI Health, Inc., Order of Suspension of Trading September 11, 2015. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of NMI Health, Inc. (CIK No. 1088213), a Nevada corporation with its principal place of business listed as Reno, Nevada with stock quoted on OTC Link (previously, ‘‘Pink Sheets’’) operated by OTC Markets Group, Inc. (‘‘OTC Link’’) under the ticker symbol NANM, because it has not filed any periodic reports since it filed a Form 10–K for the period ended December 31, 2013. On August 15, 2014, a delinquency letter was sent by the Division of Corporation Finance to NMI Health, Inc. requesting compliance with their periodic filing obligations, and the letter was received by NMI Health, Inc. on August 18, 2014. 12 17 Jkt 235001 PO 00000 CFR 200.30–3(a)(12). Frm 00089 Fmt 4703 Sfmt 4703 The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of NMI Health, Inc. Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of NMI Health, Inc. is suspended for the period from 9:30 a.m. EDT on September 11, 2015, through 11:59 p.m. EDT on September 24, 2015. By the Commission. Jill M. Peterson, Assistant Secretary. [FR Doc. 2015–23238 Filed 9–11–15; 11:15 am] BILLING CODE 8011–01–P SECURITIES AND EXCHANGE COMMISSION [File No. 500–1] Order of Suspension of Trading September 11, 2015. In the Matter of American Smooth Wave Ventures Inc., ASA International Ltd., Baker Manufacturing Co., Center For Wound Healing, Inc. (The), China Interactive Education, Inc., China Now, Inc., China Prosperous Clean Energy Corp., Cleopatra International Group, Inc., Craft College, Inc., Denia Enterprises, Inc., English Language Learning & Instruction System, Inc., Garman Cabinet & Millwork, Inc., KBK Capital Corp., LeapLab Corp., Lee Fine Arts, Inc. (a/k/a Commerce Holdings, Inc.), Maplex Alliance, Ltd., Obsidian Enterprises, Inc., Octavian Global Technologies, Inc., Ostashkov Industrial, Inc., Single Source Investment Group, Inc., Tupper, Inc., UBK Resources Co., Vomart International Auto Parts, Inc., Wilson Creek Mining Corp., Yuanwang Rich Selenium Agricultural Products Group Holding Co., Zhongbao International, Inc. It appears to the Securities and Exchange Commission that there is a lack of current and accurate public information concerning the securities of each of the issuers detailed below because questions have arisen as to their operating status, if any. Each of the issuers below is quoted on OTC Link operated by OTC Markets Group, Inc. The staff of the Securities and Exchange Commission has independently endeavored to determine whether any of the issuers below are operating. Each of the issuers below either confirmed they were now private companies or failed to respond to the staff’s inquiry about their operating status, did not have an operational address, or failed to provide their registered agent with an operational address. The staff of the Securities and Exchange Commission also determined that none of the issuers below has filed any information with OTC Markets Group, Inc. or the E:\FR\FM\15SEN1.SGM 15SEN1

Agencies

[Federal Register Volume 80, Number 178 (Tuesday, September 15, 2015)]
[Notices]
[Page 55410]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-23238]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


In the Matter of NMI Health, Inc., Order of Suspension of Trading

September 11, 2015.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
NMI Health, Inc. (CIK No. 1088213), a Nevada corporation with its 
principal place of business listed as Reno, Nevada with stock quoted on 
OTC Link (previously, ``Pink Sheets'') operated by OTC Markets Group, 
Inc. (``OTC Link'') under the ticker symbol NANM, because it has not 
filed any periodic reports since it filed a Form 10-K for the period 
ended December 31, 2013. On August 15, 2014, a delinquency letter was 
sent by the Division of Corporation Finance to NMI Health, Inc. 
requesting compliance with their periodic filing obligations, and the 
letter was received by NMI Health, Inc. on August 18, 2014.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of NMI Health, Inc.
    Therefore, it is ordered, pursuant to Section 12(k) of the 
Securities Exchange Act of 1934, that trading in the securities of NMI 
Health, Inc. is suspended for the period from 9:30 a.m. EDT on 
September 11, 2015, through 11:59 p.m. EDT on September 24, 2015.

    By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2015-23238 Filed 9-11-15; 11:15 am]
BILLING CODE 8011-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.